These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9925392)

  • 1. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.
    Shreve PD; Anzai Y; Wahl RL
    Radiographics; 1999; 19(1):61-77; quiz 150-1. PubMed ID: 9925392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG imaging: pitfalls and artifacts.
    Abouzied MM; Crawford ES; Nabi HA
    J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
    Shammas A; Lim R; Charron M
    Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
    Culverwell AD; Scarsbrook AF; Chowdhury FU
    Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
    Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
    Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computed tomography potential pitfalls and artifacts.
    Wang X; Koch S
    Curr Probl Diagn Radiol; 2009; 38(4):156-69. PubMed ID: 19464586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 FDG positron emission tomography and benign fractures.
    Shon IH; Fogelman I
    Clin Nucl Med; 2003 Mar; 28(3):171-5. PubMed ID: 12592121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of FDG PET in evaluation of cancer patients.
    Kostakoglu L; Agress H; Goldsmith SJ
    Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
    De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
    Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls and Misinterpretations of Cardiac Findings on PET/CT Imaging: A Careful Look at the Heart in Oncology Patients.
    Betancourt Cuellar SL; Palacio D; Benveniste MF; Carter BW; Gladish G
    Curr Probl Diagn Radiol; 2019; 48(2):172-183. PubMed ID: 29549978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
    Kubota K
    Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
    Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
    Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.
    Lakhani A; Khan SR; Bharwani N; Stewart V; Rockall AG; Khan S; Barwick TD
    Radiographics; 2017; 37(2):577-594. PubMed ID: 28287942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT.
    Maurer AH; Burshteyn M; Adler LP; Steiner RM
    Radiographics; 2011; 31(5):1287-305. PubMed ID: 21918045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole body imaging in the abdominal cancer patient: pitfalls of PET-CT.
    McDermott S; Skehan SJ
    Abdom Imaging; 2010 Feb; 35(1):55-69. PubMed ID: 19130117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic FDG PET: state of the art.
    Erasmus JJ; McAdams HP; Patz EF; Goodman PC; Coleman RE
    Radiographics; 1998; 18(1):5-20. PubMed ID: 9460106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.